blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3620470

EP3620470 - TEM8 ANTIBODIES AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.05.2024
Database last updated on 09.05.2025
FormerThe patent has been granted
Status updated on  23.06.2023
FormerGrant of patent is intended
Status updated on  20.02.2023
FormerRequest for examination was made
Status updated on  21.08.2020
FormerThe application has been published
Status updated on  07.02.2020
Most recent event   Tooltip15.11.2024Lapse of the patent in a contracting state
New state(s): BG
published on 18.12.2024  [2024/51]
Applicant(s)For all designated states
The United States of America, as represented by The Secretary, Department of Health and Human Services
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
MSC 7660
Bethesda, MD 20892-7660 / US
For all designated states
Biomed Valley Discoveries, Inc.
4520 Main Street
16th Floor
Kansas City, Missouri 64111 / US
[2020/11]
Inventor(s)01 / DIMITROV, Dimiter
1019 Storrington Dirve
Frederick, MD 21702 / US
02 / ZHU, Zhongyu
2501 Carrington Way
Frederick, MD 21702 / US
03 / ST. CROIX, Brad
9010 Allington Manor Circle West
Frederick, MD 21703 / US
04 / ZUDAIRE, Enrique
The Janssen Pharmaceutical Companies
of Johnson & Johnson
1400 McKean Road
Sorint House, PA 19477 / US
05 / SAHA, Saurabh
44 Carlsbrooke Road
Wellesley Hills, MA 02481 / US
06 / ZHANG, Xiaoyan Michelle
3 Kitson Park Drive
Lexington, MA 02421 / US
07 / DECRESCENZO, Gary
4520 Main Street
16th Floor
Kansas City, MO 64111 / US
08 / WELSCH, Dean
4520 Main Street
16th Floor
Kansas City, MO 64111 / US
 [2020/11]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[2023/30]
Former [2020/11]Gowshall, Jonathan Vallance
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date19201975.013.10.2014
[2020/11]
Priority number, dateUS201361889958P11.10.2013         Original published format: US 201361889958 P
[2020/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3620470
Date:11.03.2020
Language:EN
[2020/11]
Type: B1 Patent specification 
No.:EP3620470
Date:26.07.2023
Language:EN
[2023/30]
Search report(s)(Supplementary) European search report - dispatched on:EP11.02.2020
ClassificationIPC:C07K16/28, A61P35/00, A61K47/68, A61P31/04, C07H21/04, // A61K39/00
[2020/11]
CPC:
C07K16/28 (EP,US); A61K39/39558 (US); A61K45/06 (US);
A61K47/68031 (EP,US); A61K47/6849 (EP,US); A61K47/6851 (EP,US);
A61K47/6855 (US); A61K47/6865 (US); A61K49/16 (US);
A61K9/0019 (US); A61P31/04 (EP,US); A61P35/00 (EP,US);
C07H21/04 (EP,US); C07K14/7051 (US); C07K16/30 (US);
C07K16/3046 (US); C12N15/09 (US); C12N15/63 (US);
G01N33/574 (US); G01N33/57419 (US); A61K2039/505 (EP,US);
A61K2039/54 (US); C07K2317/21 (EP,US); C07K2317/54 (US);
C07K2317/55 (US); C07K2317/56 (US); C07K2317/565 (US);
C07K2317/567 (US); C07K2317/622 (EP,US); C07K2317/76 (EP,US);
C07K2317/92 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/39]
Former [2020/11]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:TEM-8-ANTIKÖRPER UND DEREN VERWENDUNG[2020/11]
English:TEM8 ANTIBODIES AND THEIR USE[2020/11]
French:ANTICORPS TEM8 ET LEUR UTILISATION[2020/11]
Examination procedure13.08.2020Amendment by applicant (claims and/or description)
13.08.2020Examination requested  [2020/39]
13.08.2020Date on which the examining division has become responsible
21.02.2023Communication of intention to grant the patent
15.06.2023Fee for grant paid
15.06.2023Fee for publishing/printing paid
15.06.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14789480.2  / EP3054987
Divisional application(s)EP23181092.0  / EP4269421
Opposition(s)29.04.2024No opposition filed within time limit [2024/27]
Fees paidRenewal fee
08.10.2019Renewal fee patent year 03
08.10.2019Renewal fee patent year 04
08.10.2019Renewal fee patent year 05
08.10.2019Renewal fee patent year 06
14.10.2020Renewal fee patent year 07
29.09.2021Renewal fee patent year 08
28.09.2022Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.07.2023
BG26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SI26.07.2023
SK26.07.2023
SM26.07.2023
IE13.10.2023
LU13.10.2023
NO26.10.2023
GR27.10.2023
BE31.10.2023
CH31.10.2023
IS26.11.2023
PT27.11.2023
[2024/51]
Former [2024/46]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SI26.07.2023
SK26.07.2023
SM26.07.2023
IE13.10.2023
LU13.10.2023
NO26.10.2023
GR27.10.2023
BE31.10.2023
CH31.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/36]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SI26.07.2023
SK26.07.2023
SM26.07.2023
LU13.10.2023
NO26.10.2023
GR27.10.2023
BE31.10.2023
CH31.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/34]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
LU13.10.2023
NO26.10.2023
GR27.10.2023
CH31.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/30]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
LU13.10.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/28]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
MC26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/23]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/22]AT26.07.2023
CZ26.07.2023
DK26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/20]AT26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RS26.07.2023
SE26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/10]AT26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RS26.07.2023
SE26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/09]AT26.07.2023
FI26.07.2023
LT26.07.2023
NL26.07.2023
SE26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
Former [2024/08]LT26.07.2023
NL26.07.2023
NO26.10.2023
GR27.10.2023
Former [2024/05]NL26.07.2023
Documents cited:Search[I]WO2012174160  (US HEALTH [US], et al);
 [A]WO2012172495  (NOVARTIS AG [CH], et al);
by applicantUS498298
 US3060165
 US3896111
 US4036945
 US4137230
 US4151042
 US4235871
 US4248870
 US4256746
 US4260608
 US4265814
 US4294757
 US4307016
 US4308268
 US4308269
 US4309428
 US4313946
 US4315929
 US4317821
 US4322348
 US4331647
 US4331598
 US4361650
 US4362663
 US4364866
 US4371533
 US4424219
 US4450254
 US4458066
 US4486414
 US4501728
 US4689401
 US4722848
 US4816444
 US4837028
 US4879278
 US4880935
 US4892827
 US4902505
 US4946778
 US4957735
 US4978744
 US4986988
 US5004697
 EP0425235
 US5019369
 US5055303
 US5076973
 US5079163
 US5122368
 US5138036
 US5188837
 US5208020
 US5208021
 US5254342
 US5268164
 US5271961
 US5410024
 US5413797
 US5416064
 US5504191
 US5506206
 US5512658
 US5514670
 US5521284
 US5530097
 US5530020
 US5534496
 US5554725
 US5585089
 US5589466
 US5593972
 US5599902
 US5602095
 US5608039
 US5622929
 US5635483
 US5643578
 WO9730087
 US5663149
 US5665860
 US5780588
 US5792458
 US5817637
 US5821238
 US5824805
 US5854044
 WO9858964
 US5880103
 WO9922764
 US5912264
 WO9951643
 WO9954440
 US6034065
 WO0061739
 US6214345
 WO0129246
 US6239104
 US6323315
 WO0231140
 US6441163
 US2002164328
 WO02088172
 WO03002609
 WO03011878
 US2003083263
 US2003115614
 US6602684
 US2003157108
 US6610860
 WO03085119
 WO03084570
 WO03085107
 WO2004010957
 WO2004018478
 US6723538
 US2004093621
 US2004110704
 US2004110282
 US2004109865
 US2004132140
 WO2004056312
 WO2005035572
 WO2005035586
 WO2005035778
 US6884869
 US2005123546
 WO2005053742
 US2005238649
 WO2006003448
 US2006024317
 US2006074008
 US7112324
 WO2007016150
 US7229760
 US7235641
 US2007258987
 US7323440
 US7332168
 WO2008077546
 US7435549
 US2008305044
 US7498298
 WO2009032954
 US7575923
 US7635472
 US2010093979
 US7820166
 WO2011032022
 US2011070248
 US7919089
 US7964567
 US8007796
 US2011212088
 US8017748
 US2011268751
 US8076459
 WO2012079000
 US2012213783
 WO2012174160
 WO2013059593
 WO2013126726
 WO2013163427
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.